The chemours company agrees to sell glycolic acid business to iron path capital-backed puretech scientific inc. for $137 million

Wilmington, del., & nashville, tenn.--(business wire)--the chemours company (chemours) (nyse: cc), a global chemistry company with leading market positions in titanium technologies, thermal & specialized solutions, and advanced performance materials has entered into a definitive agreement to sell its glycolic acid business (“glycolic acid”) for $137 million in cash to puretech scientific inc., a company founded and backed by iron path capital, a private equity firm focused on lower-middle m.
CC Ratings Summary
CC Quant Ranking